ARTICLE | Clinical News
Solbec Pharmaceuticals Ltd preclinical data
August 8, 2005 7:00 AM UTC
In a mouse model of mesothelioma, Coramsine plus CpG immunostimulant led to tumor regression in all 4 mice. Of these, 2 went into remission. And of these 2, one was immune when re-inoculated with canc...